Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme.
Elisa De CarloLorenzo GerratanaGiovanna De MaglioVanessa BuoroFrancesco CortiulaLorena GurrieriMiriam IsolaGianpiero FasolaFabio PuglisiStefano PizzolittoSimona RizzatoPublished in: Journal of neuro-oncology (2018)
The present manuscript explored a novel scoring system capable to take into consideration the methylation status of each single CpGi, capable to better predict prognosis in GBM patients.